By DOUG SHERWIN, The Daily Transcript
Monday, June 18, 2007
The Rady School of Management’s first class of full-time MBA students is set to graduate today.
The group of 55 pioneering students joined the Rady School at the University of California, San Diego in September 2005.
Graduates have accepted positions in Los Angeles, New York, Omaha, San Diego, San Francisco, China and Singapore.
“The full-time MBA class of 2007 leaves an extraordinary legacy as the first full-time MBA class on this campus,” said UCSD Chancellor Marye Anne Fox. “The San Diego regional business community advocated for an MBA program at our university, and I am confident that the Rady School graduates’ future business and community endeavors will make us proud.”
Since joining the Rady School, the class of 2007 has created the student government and other organizations, including a finance club, a marketing club, a chapter of Net Impact and a life sciences and technology club. They also assisted in raising funds for the school’s new building and for student fellowships.
“The full-time MBA students have made an incredible impact on the Rady School,” said Robert S. Sullivan, dean of the Rady School. “They have created student clubs, made professional contacts domestically and globally and created a true sense of community for future classes of the school.”
The graduation speaker is Michael Milken, chairman of the Milken Institute and of FasterCures, a Washington-based think tank that works to eliminate barriers to progress against all life-threatening diseases. Fortune magazine called Milken “The Man Who Changed Medicine” for his 35 years of accelerating medical solutions – work that resonates with the Rady School, whose focus is “innovation to impact.”
Graduates have accepted positions in consulting, general management, finance and marketing. Employers include Amylin, Applied Biosystems, Barclay’s Capital, Chevron, Genentech, GenVault, Hewlett-Packard, IMS Health, Millipore, Provide Commerce (ProFlowers) and PRTM. One group of 2007 full-time MBAs is currently seeking funding for a cancer biotechnology venture and plan to start the company here in San Diego.
Story quoted from the San Diego Daily Transcript.